Skip to main content

Advertisement

Open Peer Review Reports for: Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 Sep 2006 Submitted Original manuscript
30 Jan 2007 Reviewed Reviewer Report - Christopher Azzoli
24 Apr 2007 Author responded Author comments - Demosthenes Makris
Resubmission - Version 2
24 Apr 2007 Submitted Manuscript version 2
28 May 2007 Reviewed Reviewer Report - Christopher Azzoli
24 Jun 2007 Author responded Author comments - Demosthenes Makris
Resubmission - Version 3
24 Jun 2007 Submitted Manuscript version 3
1 Aug 2007 Author responded Author comments - Demosthenes Makris
Resubmission - Version 4
1 Aug 2007 Submitted Manuscript version 4
Publishing
5 Aug 2007 Editorially accepted
5 Aug 2007 Article published 10.1186/1471-2407-7-150

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement